• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用心脏磁共振特征的机器学习用于心脏再同步治疗后的多维反应和生存分析

Machine learning for multidimensional response and survival after cardiac resynchronization therapy using features from cardiac magnetic resonance.

作者信息

Bivona Derek J, Tallavajhala Srikar, Abdi Mohamad, Oomen Pim J A, Gao Xu, Malhotra Rohit, Darby Andrew E, Monfredi Oliver J, Mangrum J Michael, Mason Pamela K, Mazimba Sula, Salerno Michael, Kramer Christopher M, Epstein Frederick H, Holmes Jeffrey W, Bilchick Kenneth C

机构信息

Department of Medicine, University of Virginia Health System, Charlottesville, Virginia.

Department of Biomedical Engineering, University of Virginia Health System, Charlottesville, Virginia.

出版信息

Heart Rhythm O2. 2022 Jun 17;3(5):542-552. doi: 10.1016/j.hroo.2022.06.005. eCollection 2022 Oct.

DOI:10.1016/j.hroo.2022.06.005
PMID:36340495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9626744/
Abstract

BACKGROUND

Cardiac resynchronization therapy (CRT) response is complex, and better approaches are required to predict survival and need for advanced therapies.

OBJECTIVE

The objective was to use machine learning to characterize multidimensional CRT response and its relationship with long-term survival.

METHODS

Associations of 39 baseline features (including cardiac magnetic resonance [CMR] findings and clinical parameters such as glomerular filtration rate [GFR]) with a multidimensional CRT response vector (consisting of post-CRT left ventricular end-systolic volume index [LVESVI] fractional change, post-CRT B-type natriuretic peptide, and change in peak VO) were evaluated. Machine learning generated response clusters, and cross-validation assessed associations of clusters with 4-year survival.

RESULTS

Among 200 patients (median age 67.4 years, 27.0% women) with CRT and CMR, associations with more than 1 response parameter were noted for the CMR CURE-SVD dyssynchrony parameter (associated with post-CRT brain natriuretic peptide [BNP] and LVESVI fractional change) and GFR (associated with peak VO and post-CRT BNP). Machine learning defined 3 response clusters: cluster 1 (n = 123, 90.2% survival [best]), cluster 2 (n = 45, 60.0% survival [intermediate]), and cluster 3 (n = 32, 34.4% survival [worst]). Adding the 6-month response cluster to baseline features improved the area under the receiver operating characteristic curve for 4-year survival from 0.78 to 0.86 ( = .02). A web-based application was developed for cluster determination in future patients.

CONCLUSION

Machine learning characterizes distinct CRT response clusters influenced by CMR features, kidney function, and other factors. These clusters have a strong and additive influence on long-term survival relative to baseline features.

摘要

背景

心脏再同步治疗(CRT)反应复杂,需要更好的方法来预测生存率以及对高级治疗的需求。

目的

目的是使用机器学习来描述多维CRT反应及其与长期生存的关系。

方法

评估了39个基线特征(包括心脏磁共振成像[CMR]结果和临床参数,如肾小球滤过率[GFR])与多维CRT反应向量(由CRT后左心室收缩末期容积指数[LVESVI]的分数变化、CRT后B型利钠肽以及峰值VO的变化组成)之间的关联。机器学习生成反应簇,交叉验证评估簇与4年生存率之间的关联。

结果

在200例接受CRT和CMR检查的患者(中位年龄67.4岁,27.0%为女性)中,CMR CURE-SVD不同步参数(与CRT后脑利钠肽[BNP]和LVESVI分数变化相关)和GFR(与峰值VO和CRT后BNP相关)与多个反应参数存在关联。机器学习定义了3个反应簇:簇1(n = 123,生存率90.2%[最佳])、簇2(n = 45,生存率60.0%[中等])和簇3(n = 32,生存率34.4%[最差])。将6个月时的反应簇添加到基线特征中,使4年生存率的受试者工作特征曲线下面积从0.78提高到0.86(P = 0.02)。开发了一个基于网络的应用程序,用于确定未来患者的簇。

结论

机器学习描述了受CMR特征、肾功能和其他因素影响的不同CRT反应簇。相对于基线特征,这些簇对长期生存有强烈且累加的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af08/9626744/26c552ede064/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af08/9626744/15fb16500d93/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af08/9626744/08b5addb950a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af08/9626744/20453d4dbbce/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af08/9626744/788b2fa99dd9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af08/9626744/26c552ede064/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af08/9626744/15fb16500d93/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af08/9626744/08b5addb950a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af08/9626744/20453d4dbbce/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af08/9626744/788b2fa99dd9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af08/9626744/26c552ede064/gr4.jpg

相似文献

1
Machine learning for multidimensional response and survival after cardiac resynchronization therapy using features from cardiac magnetic resonance.利用心脏磁共振特征的机器学习用于心脏再同步治疗后的多维反应和生存分析
Heart Rhythm O2. 2022 Jun 17;3(5):542-552. doi: 10.1016/j.hroo.2022.06.005. eCollection 2022 Oct.
2
Cardiac magnetic resonance defines mechanisms of sex-based differences in outcomes following cardiac resynchronization therapy.心脏磁共振成像确定了心脏再同步治疗后基于性别的结局差异机制。
Front Cardiovasc Med. 2022 Sep 15;9:1007806. doi: 10.3389/fcvm.2022.1007806. eCollection 2022.
3
CMR DENSE and the Seattle Heart Failure Model Inform Survival and Arrhythmia Risk After CRT.CMR DENSE 和西雅图心力衰竭模型为 CRT 后生存和心律失常风险提供信息。
JACC Cardiovasc Imaging. 2020 Apr;13(4):924-936. doi: 10.1016/j.jcmg.2019.10.017. Epub 2019 Dec 18.
4
Cardiac Magnetic Resonance Assessment of Response to Cardiac Resynchronization Therapy and Programming Strategies.心脏磁共振评估心脏再同步治疗反应和程控策略。
JACC Cardiovasc Imaging. 2021 Dec;14(12):2369-2383. doi: 10.1016/j.jcmg.2021.06.015. Epub 2021 Aug 18.
5
Importance of Systematic Right Ventricular Assessment in Cardiac Resynchronization Therapy Candidates: A Machine Learning Approach.重要性的系统右心室评估在心脏再同步治疗候选者:一种机器学习的方法。
J Am Soc Echocardiogr. 2021 May;34(5):494-502. doi: 10.1016/j.echo.2020.12.025. Epub 2021 Jan 7.
6
The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study.心脏再同步治疗对轻度症状性心力衰竭患者长期生存的逆向重构作用:REVERSE研究结果
Heart Rhythm. 2015 Mar;12(3):524-530. doi: 10.1016/j.hrthm.2014.11.014. Epub 2014 Nov 15.
7
Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.房室延迟程控和心脏再同步治疗在 MADIT-CRT 中的获益。
Heart Rhythm. 2013 Aug;10(8):1136-43. doi: 10.1016/j.hrthm.2013.04.013. Epub 2013 May 25.
8
Using Machine-Learning for Prediction of the Response to Cardiac Resynchronization Therapy: The SMART-AV Study.使用机器学习预测心脏再同步治疗反应:SMART-AV 研究。
JACC Clin Electrophysiol. 2021 Dec;7(12):1505-1515. doi: 10.1016/j.jacep.2021.06.009. Epub 2021 Aug 25.
9
Machine learning of ECG waveforms and cardiac magnetic resonance for response and survival after cardiac resynchronization therapy.基于心电图波形和心脏磁共振的机器学习预测心脏再同步化治疗后的反应和生存。
Comput Biol Med. 2024 Aug;178:108627. doi: 10.1016/j.compbiomed.2024.108627. Epub 2024 May 22.
10
Impact of mechanical activation, scar, and electrical timing on cardiac resynchronization therapy response and clinical outcomes.机械激活、瘢痕和电定时对心脏再同步治疗反应和临床结果的影响。
J Am Coll Cardiol. 2014 Apr 29;63(16):1657-66. doi: 10.1016/j.jacc.2014.02.533. Epub 2014 Mar 5.

引用本文的文献

1
Role of Artificial Intelligence and Machine Learning to Create Predictors, Enhance Molecular Understanding, and Implement Purposeful Programs for Myocardial Recovery.人工智能和机器学习在创建预测器、增强分子理解和实施有目的的心肌恢复计划中的作用。
Methodist Debakey Cardiovasc J. 2024 Aug 20;20(4):76-87. doi: 10.14797/mdcvj.1392. eCollection 2024.
2
Measuring Cardiac Dyssynchrony with DENSE (Displacement Encoding with Stimulated Echoes)-A Systematic Review.使用DENSE(刺激回波位移编码)测量心脏失同步——一项系统评价。
Rev Cardiovasc Med. 2023 Sep 18;24(9):261. doi: 10.31083/j.rcm2409261. eCollection 2023 Sep.
3

本文引用的文献

1
Using Machine-Learning for Prediction of the Response to Cardiac Resynchronization Therapy: The SMART-AV Study.使用机器学习预测心脏再同步治疗反应:SMART-AV 研究。
JACC Clin Electrophysiol. 2021 Dec;7(12):1505-1515. doi: 10.1016/j.jacep.2021.06.009. Epub 2021 Aug 25.
2
Relationship of ejection fraction and natriuretic peptide trajectories in heart failure with baseline reduced and mid-range ejection fraction.射血分数与心力衰竭中基线射血分数降低和中间范围的利钠肽轨迹的关系。
Am Heart J. 2022 Jan;243:1-10. doi: 10.1016/j.ahj.2021.08.015. Epub 2021 Aug 25.
3
Cardiac Magnetic Resonance Assessment of Response to Cardiac Resynchronization Therapy and Programming Strategies.
Improving the efficiency and accuracy of cardiovascular magnetic resonance with artificial intelligence-review of evidence and proposition of a roadmap to clinical translation.
利用人工智能提高心血管磁共振成像的效率和准确性——证据综述及临床转化路线图建议
J Cardiovasc Magn Reson. 2024;26(2):101051. doi: 10.1016/j.jocmr.2024.101051. Epub 2024 Jun 22.
4
Machine learning of ECG waveforms and cardiac magnetic resonance for response and survival after cardiac resynchronization therapy.基于心电图波形和心脏磁共振的机器学习预测心脏再同步化治疗后的反应和生存。
Comput Biol Med. 2024 Aug;178:108627. doi: 10.1016/j.compbiomed.2024.108627. Epub 2024 May 22.
5
Cardiac Magnetic Resonance, Electromechanical Activation, Kidney Function, and Natriuretic Peptides in Cardiac Resynchronization Therapy Upgrades.心脏再同步治疗升级中的心脏磁共振、机电激活、肾功能和利钠肽
J Cardiovasc Dev Dis. 2023 Sep 22;10(10):409. doi: 10.3390/jcdd10100409.
6
Artificial intelligence models in prediction of response to cardiac resynchronization therapy: a systematic review.人工智能模型在预测心脏再同步治疗反应中的应用:系统评价。
Heart Fail Rev. 2024 Jan;29(1):133-150. doi: 10.1007/s10741-023-10357-8. Epub 2023 Oct 20.
7
Noninvasive Electrical Mapping Compared with the Paced QRS Complex for Optimizing CRT Programmed Settings and Predicting Multidimensional Response.非侵入性电描记术与起搏 QRS 波群比较,用于优化 CRT 程控设置和预测多维反应。
J Cardiovasc Transl Res. 2023 Dec;16(6):1448-1460. doi: 10.1007/s12265-023-10418-1. Epub 2023 Sep 6.
8
The saga of dyssynchrony imaging: Are we getting to the point.不同步成像的传奇故事:我们是否已到关键节点。
Front Cardiovasc Med. 2023 Mar 31;10:1111538. doi: 10.3389/fcvm.2023.1111538. eCollection 2023.
9
First-in-human noninvasive left ventricular ultrasound pacing: A potential screening tool for cardiac resynchronization therapy.首例人体无创性左心室超声起搏:心脏再同步治疗的一种潜在筛查工具。
Heart Rhythm O2. 2022 Oct 22;4(2):79-87. doi: 10.1016/j.hroo.2022.10.008. eCollection 2023 Feb.
10
Cardiac magnetic resonance defines mechanisms of sex-based differences in outcomes following cardiac resynchronization therapy.心脏磁共振成像确定了心脏再同步治疗后基于性别的结局差异机制。
Front Cardiovasc Med. 2022 Sep 15;9:1007806. doi: 10.3389/fcvm.2022.1007806. eCollection 2022.
心脏磁共振评估心脏再同步治疗反应和程控策略。
JACC Cardiovasc Imaging. 2021 Dec;14(12):2369-2383. doi: 10.1016/j.jcmg.2021.06.015. Epub 2021 Aug 18.
4
A Randomized Trial of His Pacing Versus Biventricular Pacing in Symptomatic HF Patients With Left Bundle Branch Block (His-Alternative).希氏束起搏与双心室起搏治疗左束支传导阻滞伴症状性心力衰竭患者的随机试验(希氏束起搏替代)。
JACC Clin Electrophysiol. 2021 Nov;7(11):1422-1432. doi: 10.1016/j.jacep.2021.04.003. Epub 2021 Apr 25.
5
Left Bundle Branch Area Pacing for Cardiac Resynchronization Therapy: Results From the International LBBAP Collaborative Study Group.心脏再同步治疗的左束支区域起搏:国际左束支区域起搏协作研究组的结果
JACC Clin Electrophysiol. 2021 Feb;7(2):135-147. doi: 10.1016/j.jacep.2020.08.015. Epub 2020 Oct 28.
6
CMR DENSE and the Seattle Heart Failure Model Inform Survival and Arrhythmia Risk After CRT.CMR DENSE 和西雅图心力衰竭模型为 CRT 后生存和心律失常风险提供信息。
JACC Cardiovasc Imaging. 2020 Apr;13(4):924-936. doi: 10.1016/j.jcmg.2019.10.017. Epub 2019 Dec 18.
7
Cardiac Biomarkers in Advanced Heart Failure: How Can They Impact Our Pre-transplant or Pre-LVAD Decision-making.晚期心力衰竭中的心脏生物标志物:它们如何影响我们的移植前或左心室辅助装置植入前决策。
Curr Heart Fail Rep. 2019 Dec;16(6):274-284. doi: 10.1007/s11897-019-00447-w.
8
Machine Learning Prediction of Response to Cardiac Resynchronization Therapy: Improvement Versus Current Guidelines.机器学习预测心脏再同步治疗反应:改善与现行指南比较。
Circ Arrhythm Electrophysiol. 2019 Jul;12(7):e007316. doi: 10.1161/CIRCEP.119.007316. Epub 2019 Jun 20.
9
B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.沙库巴曲缬沙坦治疗期间的 B 型利钠肽:PARADIGM-HF 试验。
J Am Coll Cardiol. 2019 Mar 26;73(11):1264-1272. doi: 10.1016/j.jacc.2019.01.018. Epub 2019 Mar 4.
10
Gradual reduction in exercise capacity in chronic kidney disease is associated with systemic oxygen delivery factors.慢性肾脏病患者的运动能力逐渐下降与全身氧输送因素有关。
PLoS One. 2018 Dec 19;13(12):e0209325. doi: 10.1371/journal.pone.0209325. eCollection 2018.